# US 10,869,996 B2 · Method and apparatus for sequential deployment of intra-tumoral agents > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 10,869,996 B2 - Document ID: US10869996B2 - Status: Granted - Kind: B2 - Application number: 15/338,343 - Filed: 2016-10-29 - Published: 2020-04-02 - Granted: 2020-12-22 - Earliest claimed: 2016-10-29 - Applicants: Stephen Kuperberg - Inventors: Stephen Kuperberg - Web page: https://patentgrep.com/patent/US10869996B2 ## CPC - A61F 2/04: Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts (A61F2/18, A61F2/20 take precedence; instruments specially adapted for placement or removal of stents or stent-grafts A61F2/95) - A61M 31/002: {Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time (artificial gland structures or devices A61F2/022; intra-uterine contraceptive devices A61F6/14; tampons for introducing into the vagina A61F13/20, A61L15/00; suppositories or bougies for intra-vaginal or intra-uterine application A61K9/02; physical forms of medicinal preparations for sustained or differential drug release A61K9/20, A61K9/50)} - A61B 1/015: Control of fluid supply or evacuation - A61B 1/2676: {Bronchoscopes} - A61B 17/3211: Surgical scalpels, knives; Accessories therefor - A61B 17/320016: {Endoscopic cutting instruments, e.g. arthroscopes, resectoscopes (A61B10/0233, A61B17/29, A61B17/3207 take precedence)} - A61B 2017/00809: {Lung operations} - A61B 2017/00893: {pharmaceutically effective} - A61B 2017/22044: {with a pointed tip} - A61F 2/0063: {Implantable repair or support meshes, e.g. hernia meshes} - A61F 2002/043: {Bronchi} - A61F 2250/0067: Means for introducing or releasing pharmaceutical products into the body - A61M 2210/1035: Bronchi - A61M 2210/1039: Lungs - A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C) - A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)} - A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D) ## Abstract An intra-tumoral agent deployment apparatus for diagnosing and delivering targeted, sequential deployment of agents to an endo-bronchial and, or an intra-parenchymal tumor, said apparatus formed of, among other things, an elongated shaft assembly including: at least one lumen; an intra-tumoral probe wire for tumor traversal, slidably interposed there between or slidably disposed between any one of, or combination of the at least one lumen; and wherein the displacement of the intra-tumoral probe wire causes disruption of an endo-bronchial and, or an intra-parenchymal tumor tissue, and, or creating an inlet for deployment of at least a first agent comprising any one of a therapeutic agent and, or a delivery vehicle from the first lumen, and a subsequent second agent comprising any one of a therapeutic agent and, or a binding agent from any one of the first lumen, second lumen, and, or the delivery vehicle. ## Claims ### Claim 1 An apparatus for sequential deployment of intra-tumoral agents, said apparatus comprising: an elongated shaft assembly including: a distal end portion with at least one port opening; at least a first and second lumen axially disposed within the elongated shaft assembly, the at least first and second lumen extending through the shaft and engaged to the at least one port opening at the distal end, wherein the first lumen comprises a therapeutic agent for deployment and the second lumen comprises a binding agent for subsequent deployment; an intra-tumoral probe wire slidably interposed there between or slidably disposed between any one of, or combination of the at least first and second lumen; a proximal end housing a finger-led control coupled to an actuator, whereby said actuator is in operable communication to any one of, or combination of, the at least one port opening, protraction, retraction, and deployment of the intra-tumoral probe wire and, or a deployment line fittingly disposed between and, or within any of the at least first and second lumen, said deployment line operably coupled to and causing displacement of any one of an agent, at least one port, and, or intra-tumoral probe wire; and wherein the displacement of the intra-tumoral probe wire interposed there between or slidably disposed between any one of, or combination of, the at least first and second lumen causes disruption of a tumor tissue and forms an inlet for displacement of a first agent comprising any one of a therapeutic agent from the first lumen and a subsequently deployed second agent comprising any one of a binding agent from the second lumen, wherein the binding agent encapsulates and/or calcifies the tumor for prolonged exposure of the tumor to the therapeutic agent. ### Claim 2 (depends on 1) The sequential intra-tumoral agent deployment apparatus of claim 1 further comprising a third lumen for housing the intra-tumoral probe wire and at least one of a therapeutic agent and/or binding: agent. ### Claim 3 (depends on 1) The sequential intra-tumoral agent deployment apparatus of claim 1 further comprising a single deployment line disposed within at least one of the first lumen, second lumen, and, or there between, wherein the single deployment line is in operable communication with pivotally-opposed arms at the distal end for actuating any one of, or combination of, port openings or displacement of intra-tumoral probe wire. ### Claim 4 (depends on 1) The sequential intra-tumoral agent deployment apparatus of claim 1, wherein the distal end of the elongated shaft assembly is further disposed with a tumor location guide. ### Claim 5 (depends on 4) The sequential intra-tumoral agent deployment apparatus of claim 4, wherein the tumor location guide uses ultrasound detection for locating the tumor and guiding the intra-tumoral probe wire. ### Claim 6 (depends on 1) The sequential intra-tumoral agent deployment apparatus of claim 1, wherein said apparatus is slidably disposed within a tubular member of any one of a flexible or rigid bronchoscope, wherein the apparatus is configured to operate under any one of, or combination of, a control circuitry, control module, control unit, and, or control operator of any one of, or combination of the apparatus or the bronchoscope. ### Claim 7 (depends on 1) The sequential intra-tumoral agent deployment apparatus of claim 1, wherein said apparatus is slidably disposed within a tubular member of any one of a flexible or rigid bronchoscope, wherein the bronchoscope is configured to release the first agent from the first lumen of the apparatus and the second agent from the second lumen of the apparatus, wherein the bronchoscope is configured to operate under any one of, or combination of, a control circuitry, control module, control unit, and, or control operator of any one of, or combination of the apparatus or the bronchoscope. ### Claim 8 (depends on 6) The sequential intra-tumoral agent deployment apparatus of claim 6, wherein the bronchoscope guides the distal tip of the apparatus towards at least one of a tumor or lesion. ### Claim 9 (depends on 1) The sequential intra-tumoral agent deployment apparatus of claim 1, wherein the distal tip of any one of, or combination of, the apparatus or a bronchoscope further comprises a fluoroscope for confirmation of location of any one of a tumor or a lesion. ### Claim 10 (depends on 1) The sequential intra-tumoral agent deployment apparatus of claim 1, wherein the first agent is any one of, or combination off a chemotherapeutic agent, stem-cell therapeutic agent, immune-based therapeutic agent, or nano-based therapeutic agent including any one of dendrimers, micelles or nanotubes. ### Claim 11 (depends on 1) The sequential intra-tumoral agent deployment apparatus of claim 1, wherein any one of the first agent, and, or the second agent is a nano-based particle, whereby said particle is a carrier of any one of, or combination of, a chemo-based therapy, stem cell therapy, immuno-based therapy, nano-based therapy or a binding agent. ### Claim 12 (depends on 1) The sequential intra-tumoral agent deployment apparatus of claim 1, wherein at least two lumens are rotatably disposed within the elongated shaft assembly, whereby the first lumen with the first agent is subsequently interposed with the second lumen with the second agent to produce a sequential deployment of the first agent and then the second agent at a same ablation target. ### Claim 13 (depends on 10) The sequential intra-tumoral agent deployment apparatus of claim 10; wherein a delivery vehicle with the therapeutic agent, such as a capsule, tablet, hydrogel, liquid, and, or other polymer delivering the therapeutic agent; and a second deployment being a slow-acting release of the therapeutic agent from the delivery vehicle. ### Claim 14 (depends on 10) The sequential intra-tumoral agent deployment apparatus of claim 10, wherein a first deployment being the therapeutic agent from a lumen; and a second deployment being a binding agent from any one of the same lumen and the second lumen, whereby the binding agent calcifies the tumor for prolonged exposure of the therapeutic agent. ### Claim 15 (depends on 10) The sequential intra-tumoral agent deployment apparatus of claim 10, wherein a first deployment being the therapeutic agent from a lumen; and a second deployment being a binding agent from any one of the same lumen and the second lumen, whereby the binding agent is a surgical wire mesh to encapsulate the tumor and prolong exposure of the therapeutic agent. ### Claim 16 (depends on 1) The sequential intra-tumoral agent deployment apparatus of claim 1, wherein any one of targeting, probing, and, or sequential deployment of the first agent and the second agent is directed toward an endo-bronchial or intra-parenchymal tumor. ### Claim 17 A method of sequentially deploying intra-tumoral agents, said method comprising the steps of: fitting at least a first and second lumen axially within the elongated shaft assembly, said first and second lumen extending through the shaft and engaged to at least one port at the distal end; interposing an intra-tumoral probe wire slidably disposed within or between each of the first and second lumen; coupling a proximal end housing with a finger-led control to an actuator, whereby said actuator is in operable communication to any one of, or combination of, each lumen port opening, protraction, and, or retraction of the intra-tumoral probe wire and a deployment line fittingly disposed between and, or within each of the at least first and second lumen, said deployment line operably coupled for causing displacement of any one of the lumen port, intra-tumoral probe wire, and, or agent displacement; and disrupting a tumor and forming an inlet for local displacement of a first agent comprising a therapeutic agent from the first lumen and a subsequent deployed second agent comprising a binding agent from the second lumen, wherein the binding agent encapsulates and/or calcifies the tumor for prolonged exposure of the tumor to the therapeutic agent. ### Claim 18 (depends on 17) The method of claim 17, wherein the first agent is any one of, or combination of, a chemo-based, stem-cell based, immune-based, and, or nano-based therapy, within or without a delivery vehicle, from the first lumen and the subsequently deployed second agent is any one of a binding agent from the second lumen. ### Claim 19 A method for sequentially deploying intra-tumoral agents, said method comprising the steps of: displacing an intra-tumoral probe wire interposed or slidably disposed between or within at least a first lumen and a second lumen; and causing disruption of a tumor and forming an inlet for displacement of a first therapeutic agent comprising at least one of a chemo-based, stem-cell based, immune-based, ora nano-based therapy from the first lumen and a subsequent second binding agent comprising at least one of a calcifying or encapsulating agent from the second lumen for prolonging exposure of the tumor to the therapeutic agent for increased efficacy.